Compounded & Branded Male Hair Loss Treatment Protocol

Name	Compounded & Branded Male Hair Loss Treatment - Finasteride, Minoxidil, Dutasteride, Combination Topical & Oral Therapies
Uses	Treatment of androgenetic alopecia (male pattern baldness), promoting hair regrowth and reducing hair loss.
Route Of Administration	Oral (tablet/capsule), Topical (solution, foam, compounded formulations).
Frequency Of Use	Oral: once daily; Topical: once or twice daily based on formulation and provider recommendation.
Concentration(s)	Finasteride: 1 mg (oral), 0.1-0.5% (topical); Minoxidil: 2%, 5%, 10% (topical); Dutasteride: 0.5 mg (oral).
Maximum Dosage (Day, Wk)	Finasteride: 1 mg daily; Dutasteride: 0.5 mg daily; Minoxidil: up to 5% BID or 10% once daily.
Contraindications	Pregnancy (women should not handle crushed tablets), liver disease, hypersensitivity to active ingredients, history of low blood pressure (Minoxidil caution).
Possible Side Effects	Common: scalp irritation, shedding phase, decreased libido (Finasteride/Dutasteride). Rare: dizziness, gynecomastia, post-finasteride syndrome (uncommon but documented).
Compatibility With Other Treatments/Drugs	Avoid concurrent use of oral Finasteride and Dutasteride; caution with blood pressure medications (Minoxidil can lower BP).
Allergies	Assess for hypersensitivity to Finasteride, Minoxidil, or topical solution excipients (e.g., propylene glycol).
Administration Time	Oral: take at the same time daily; Topical: apply to dry scalp, avoid washing for 4 hours post-application.
Dosing/Settings	Oral Finasteride: 1 mg daily; Oral Dutasteride: 0.5 mg daily; Topical Minoxidil: 1 mL BID (5%) or 1 mL once daily (10%).
Test Spot Requirement	Recommended: Apply a small amount of topical treatment to a test area for 24 hours before full application.
Pre-Treatment Guidelines	Ensure patient understands potential side effects, realistic expectations, and the commitment required for long-term use.
Provider Clearance Guidelines	NP, PA, MD, or DO must approve; assess liver function for oral therapy, evaluate history of hair loss progression.
Pre-Treatment Screening Workflow	1. Confirm androgenetic alopecia diagnosis. 2. Rule out reversible causes (thyroid dysfunction, nutritional deficiencies). 3. Discuss treatment expectations.
What To Do If Adverse Reaction Occurs	For mild irritation: use a lower concentration or reduce frequency. For systemic effects (e.g., dizziness, sexual dysfunction): discontinue and reassess.
Clinic Implementation Guidelines	Educate patients on continued use for sustained results; discontinuation leads to hair loss reversal.
Photographic Documentation Protocol	Baseline and follow-up photos every 3-6 months to track progress.
Post-Treatment Care	Monitor hair regrowth at follow-ups, adjust treatment as needed, ensure patient compliance with medication regimen.
Additional Documentation Requirements	Signed informed consent, progress tracking notes, patient education on side effects and expected outcomes.